Health
Results: 1837-1848 of 10167

Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer

NCCN Announces Annual Awards to Honor Leaders Who Help Expand the Reach for Essential Cancer Care Resources

Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates

Bracco Imaging and NYU Langone Health Announce Strategic Alliance Agreement to Advance Medical Imaging Innovation

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)




